ONYX-015 engineered adenovirus that replicates in and kills tumor cells deficient in p53: Phase II Update

Onyx Pharmaceuticals Inc. (ONXX), Richmond, Calif.
Product: ONYX-015 engineered

Read the full 96 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE